Bone Resorption in Ameloblastoma and Its Underlying Mechanism
Abstract
Ameloblastoma, a tumor located in the jaw, grows slowly but locally invasive. Ameloblastoma expands in the jaw based on a mechanism resorbing the surrounding bone. To date, the bone resorption mechanisms of ameloblastoma are associated with the expression of receptor activator of nuclear factor (NF)-κB (RANK) ligand (RANKL), matrix metalloproteinases (MMPs), and tumor necrosis factor (TNF)-α. RANKL plays an important role in generating osteoclastogenesis. MMPs degrade the extracellular matrix. TNF-α can induce the formation of osteoclast and modulate the MMPs. In this review the bone resorption mechanism of ameloblastoma as well its signaling pathway will be disclosed.
Keywords: Ameloblastoma, RANKL, MMPs, TNF-α.
Full Text:
PDFReferences
Al-Rawi, N.H., Al-Siraj, A.K. and Majeed, A.H., 2018, Comparison of osteoclastogenesis and local invasiveness of ameloblastoma keratocystic odontogenic tumor, Eur. J. Dent., 12(1), 36-42. CrossRef
Amirhosseini, M., Madsen, R.V., Escott, K.J., Bostrom, M.P., Ross, F.P. and Fahlgren, A., 2018, GSK-3β Inhibition Suppresses Instability-induced Osteolysis by a Dual Action on Osteoblast and Osteoclast Differentiation,J. Cell. Physiol., 233(3), 2398–2408. CrossRef
Anne, R., Krisnuhoni, E., Chotimah, C. and Latief, B.S., 2014, Matrix metalloproteinase-9 (MMP-9) expression in different subtypes of ameloblastoma, J. Maxillofac. Oral. Surg., 13(3), 281–285. CrossRef
Antonoglou, G.N. and Sandor, G.K., 2015, Recurrence rates of intraosseous ameloblastomas of the jaws: A systematic review of conservative versus aggressive treatment approaches and meta‐analysis of non‐randomized studies, Journal of Cranio‐Maxillo‐Facial Surgery, 43(1), 149–157. CrossRef
Arora, S., 2015, Unicystic ameloblastoma: A perception for the cautious interpretation of radiographic and histologic findings, J. Coll. Physician. Surg. Park., 25(10), 761-764. CrossRef
Brown, N.A., Betz, B.L., Weigelin, H.C., Elenitoba-Johnson, K.S., Lim, M.S. and Bailey, N.G., 2015, Evaluation of allele-specific PCR and immunohistochemistry for the detection of BRAF V600E mutations in hairy cell leukemia, Am. J. Clin. Pathol., 143(1), 89–99. CrossRef
Dissanayake, R.K., Jayasooriya, P.R., Siriwardena, D.J. and Tilakaratne W.M., 2011, Review of metastasizing (malignant) ameloblastoma (METAM): pattern of metastasis and treatment, Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod., 111(6), 734-41. CrossRef
Effiom, O.A., Ogundana, O.M., Akinshipo, A.O. and Akintoye, S.O., 2018, Ameloblastoma: current etiopathological concepts and management, Oral. Diseases., 24(3), 307–316. CrossRef
Feng, W., Guo, J. and Li, M., 2019, RANKL-independent modulation of osteoclastogenesis, J. Oral. Biosci, 61(1),16-21. CrossRef
Figueiredo, N.R., Dinkar, A.D., Meena, M., Sujata, S. and Manisha, K., 2014, Ameloblastoma: A clinicoradiographic and histopathologic correlation of 11 cases seen in Goa during 2008-2012, Contemp. Clin. Dent., 5(2), 16-165. CrossRef
França, L.J., Curioni, O.A., Paiva, D.L., Vianna, D.M., Dedivitis, R.A. and Rapoport, A., 2012, Ameloblastoma demographic, clinical, and treatment study: analysis of 40 cases, Braz. J. Otorhinolaryngol., 78(3), 38-41. CrossRef
Fuchigami, T., Kibe, T., Koyama, H., Kishida, S., Iijima, M., Nishizawa, Y., et al., 2014, Regulation of IL-6 and IL-8 production by reciprocal cell-to-cell interactions between tumor cells and stromal fibroblasts through IL-1α in ameloblastoma, Biochem. Biophys. Res. Commun., 451, 491–496.
Gomes, C.C., Duarte, A.P., Diniz, M.G. and Gomez, R.S., 2010, Current concepts of ameloblastoma pathogenesis, J. Oral. Pathol. Med., 39, 585-591.
Hendra, F.N., Natsir-Kalla, D.S., Van-Cann, E.M., de-Vet, H., Helder, M.N. and Forouzanfar, T., 2019, Radical vs. conservative treatment of intraosseous ameloblastoma: Systematic review and meta-analysis, Oral. Diseases., 25(7), 1683–1696.
Hendarmin, L., Sandra, F., Nakao, Y., Ohishi, M. and Nakamura, N., 2005, TNFalpha played a role in the induction of Akt and MAPK signals in ameloblastoma, Oral. Oncol., 41(4), 375-82.
Intapa, C., 2017, Analysis of Prevalence and Clinical Features of Ameloblastoma and its Histopathological Subtypes in Southeast Myanmar and Lower Northern Thailand Populations: A 13-Year Retrospective Study, J. Clin. Diagn. Res., 11(1), ZC102-ZC106.
Kamboj, M., Shreedhar, B. and Chaturvedi, M., 2015, Plexiform unicystic ameloblastoma: A case report and data analysis in the Indian population, J. Maxillofac. Oral. Surg., 14(1), 407-411.
Kibe, T., Fuchigami, T., Kishida, M., Iijima, M., Ishihata, K., Hijioka, H., et al., 2013, A novel ameloblastoma cell line (AM-3) secretes MMP-9 in response to Wnt-3a and induces osteoclastogenesis, Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol., 115(6), 780–788.
Kim, S. and Jang, H., 2001, Ameloblastoma: A clinical, radiographic, and histopathologic analysis of 71 cases, Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod., 91, 649-653.
Kreppel, M. and Zoller, J., 2018, Ameloblastoma-clinical, radiological, and therapeutic findings, Oral. Dis., 24(1-2), 63-66.
Liu, X., Chen, Z., Lan, T., Liang, P. and Tao, Q., 2019, Upregulation of interleukin-8 and activin A induces osteoclastogenesis in ameloblastoma, Int. J. Mol. Med., 43(6), 2329-2340.
Maia, E.C. and Sandrini, F.A.L., 2017, Management techniques of ameloblastoma: a literature review, RGO. Rev. Gaúch. Odontol., 65(1), 62-69.
Masthan, K., Anitha, N., Krupaa, J. and Manikkam, S., 2015, Ameloblastoma, J. Pharm. Bioall. Sci., 7, 167-70.
McClary, A.C., West, R.B., McClary, A.C., Pollack, J.R., Fischbein, N.J., Holsinger, C.F., et al., 2016, ameloblastoma: a clinical review and trends in management, Eur. Arch. Otorhinolaryngol., 273(7), 1649-1661.
More, C., Tailor, M., Patel, H.J., Asrani, M., Thakkar, K. and Adalja, C., 2012, Radiographic analysis of ameloblastoma: a retrospective study, Indian. J. Dent. Res., 23(5), 698.
Ohta, K., Naruse, T., Ishida, Y., Shigeishi, H., Nakagawa, T., Fukui, A., et al., 2017, TNF-α-induced IL-6 and MMP-9 expression in immortalized ameloblastoma cell line established by hTERT, Oral. Dis., 23(2), 199-209.
Parmar, S., Al-Qamachi, L. and Aga, H., 2016, Ameloblastomas of the mandible and maxilla, Curr. Opin. Otolaryngol. Head. Neck. Surg., 24, 148–154.
Petrovic, I.D., Migliacci, J., Ganly, I., Patel, S., Xu, B. and Ghossein, R., et al., 2018, Ameloblastomas of the mandible and maxilla, Ear. Nose. Throat. J., 97(7), E26–E32.
Pinheiro, J.J.V., Freitas, V.M., Moretti, A.I.S., Jorge, A.G., Jaeger, R.G., 2004, Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity, Histopathology., 45, 65–72.
Qahtani, K.A.L., Alkhudhayri, A.F., Islam, T., Mufargi, K.A.L., Shakweer, W.A.L. and Otaibi, F., 2019, Recurrent unicystic maxillary ameloblastoma presenting as unilateral proptosis, Saudi. J. Ophthalmol., 33(1), 94-98.
Qian, Y. and Huang, H.Z., 2010, The role of RANKL and MMP-9 in the bone resorption caused by ameloblastoma, J. Oral. Pathol. Med., 39(8), 592-598.
Rajendran, R., 2012, cyst and tumors of odontogenic origin. In: Rajendran R, Sivapathasundharam B, ed., 2012, Shafer’s Text Book of Oral Pathology, 7th ed. Indian: Elsevier. pp. 259‑313.
Ruslin, M., Hendra, F.N., Vojdani, A., Hardjosantoso, D., Gazali, M., Tajrin, A., et al., 2018, The Epidemiology, treatment, and complication of ameloblastoma in East-Indonesia: 6 years retrospective study, Med. Oral. Patol. Oral. Cir. Bucal., 23(1), e54–e58.
Saghravanian, N., Salehinejad, J., Ghazi, N., Shirdel, M. and Razi, M., 2016, A 40-year Retrospective Clinicopathological Study of Ameloblastoma in Iran, Asian. Pac. J. Cancer. Prev., 17(2), 619-623.
Sah, P., Menon, A., Kamath, A., Chandrashekar, C., Carnelio, S. and Radhakrishnan, R., 2013, Role of immunomarkers in the clinicopathological analysis of unicystic ameloblastoma, Dis. Markers., 35(5), 481–488.
Sandra, F., Hendarmin, L., Kukita, T., Nakao, Y., Nakamura, N. and Nakamura, S., 2005, Ameloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone, Oral. Oncol., 41(6), 637-644.
Sandra, F., Nakamura, N., Mitsuyasu, T., Shiratsuchi, Y. and Ohishi, M., 2001, Two relatively distinct patterns of ameloblastoma: an anti-apoptotic proliferating site in the outer layer (periphery) and a pro-apoptotic differentiating site in the inner layer (center), Histopathology., 39(1), 93-98.
Sandra, F., Mitsuyasu, T., Nakamura, N., Shiratsuchi, Y. and Ohishi, M., 2001, Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma, Oral. Oncol., 37(2),193-198.
Senguyen, B. and Oygur, T., 2011, Investigation of interleukin-1 alpha and interleukin-6 expression and interleukin-1 alpha gene polymorphism in keratocystic odontogenic tumor and ameloblastomas, Med. Oral. Patol. Oral. Cir. Bucal., 16(4), 467-72.
Singh, T., Wiesenfeld, D., Clement, J., Chandu, A. and Nastri, A., 2015, Ameloblastoma: demographic data and treatment outcomes from Melbourne, Australia, Aust. Dent. J., 60(1), 24–29.
Siqueira, A.S., Carvalho, M.R.D., Monteiro, A.C.D., Freitas, V.M., Jaeger, R.G. and Pinheiro, J.J.V., 2010, Matrix metalloproteinases, TIMPs and growth factors regulating ameloblastoma behavior, Histopathology., 57(1), 128-137.
Sun, T., Yang, W., Toprani, S. M., Guo, W., He, L., DeLeo, A.B., et al., 2020, Correction to Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram, Cell. Commun. Signal., 18(1), 53.
Tekkesin, M.S., Mutlu, S. and Olgac, V., 2011, The role of RANK/RANKL/OPG signaling pathways in osteoclastogenesis in odontogenic keratocysts, radicular cysts, and ameloblastomas, Head. Neck. Pathol., 5(3), 248-253.
Toprani, S.M., 2020, DNA damage and repair scenario in ameloblastoma, Oral. Oncol., 108, 104804.
Yang, R., Liu, Z., Peng, C., Cao, W. and Ji, T., 2017, Maxillary ameloblastoma: Factors associated with risk of recurrence, Head. & Neck., 39(5), 996–1000.
Yang, Z., Li, K., Liang, Q., Zheng, G., Zhang, S., Lao, X., et al., 2018, Elevated hydrostatic pressure promotes ameloblastoma cell invasion through upregulation of MMP-2 and MMP-9 expression via Wnt/β-catenin signaling, J. Oral. Pathol. Med., 47(9), 836-846.
Yoshimoto, S., Morita, H., Matsubara, R., Mitsuyasu, T., Imai, Y., Kajioka, S., et al., 2016, Surface vacuolar ATPase in ameloblastoma contributes to tumor invasion of the jaw bone, Int. J. Oncol., 48(3), 1258–1270.
DOI: http://dx.doi.org/10.14499/indonesianjcanchemoprev12iss1pp57-66
Copyright (c) 2021 Indonesian Journal of Cancer Chemoprevention
Indexed by:
Indonesian Society for Cancer Chemoprevention
